Global breast cancer cases are rising, even as mortality rates have declined over the past three decades, according to a comprehensive new study published in The Lancet Oncology. The research, based on the Global Burden of Diseases (GBD) study, projects a significant increase in both diagnoses and deaths by 2050, largely driven by aging populations worldwide. This complex trend in breast cancer—increasing incidence alongside decreasing mortality—highlights the evolving challenges in global health and the importance of continued investment in early detection and treatment.
Researchers analyzed data from 1990 to 2023, finding that while breast cancer mortality rates have decreased the number of new cases has steadily climbed. In Spain, mortality fell by nearly 42% during this period, a reduction attributed to expanded screening programs and access to innovative treatments in high-income countries. However, this positive trend is not expected to continue indefinitely. As populations age, both the number of cases and deaths are projected to rise, reaching an estimated 3.5 million diagnoses and 1.4 million deaths annually by mid-century.
The study underscores the critical role of early detection in improving outcomes. Increased access to screening, such as mammography, allows for earlier diagnosis and treatment, significantly reducing mortality rates. However, disparities in access to healthcare and advanced treatments remain a significant challenge, particularly in low- and middle-income countries (LMICs). According to recent reports, LMICs are disproportionately affected by the rising breast cancer burden, facing challenges related to lifestyle factors and limited resources. The Lancet Oncology reports that these nations are grappling with escalating cases.
A Global Public Health Concern
Marina Pollán, Director General of the Instituto de Salud Carlos III (ISCIII) and a cancer epidemiologist, emphasized the significance of the study’s findings. She stated that the research “highlights the burden of disease of this tumor, which constitutes a public health problem worldwide,” and points to the differing life expectancies of women with breast cancer in countries with varying income levels. Pollán also noted the study’s insights into modifiable risk factors, offering potential avenues for prevention and intervention. Her comments were made to the Science Media Centre (SMC) España.
Comparing the GBD data with figures from the Sistema de Información Español de Cáncer (SIEC), researchers found generally consistent numbers, though with some discrepancies. SIEC estimated approximately 35,540 cases in Spain for 2023, while the published article suggests a range of 24,600 to 34,400 cases. Regarding mortality, SIEC recorded 6,405 deaths in Spain in the same year, a figure lower than the 7,890 estimated in the study.
Spain’s Progress and Future Challenges
Alejandro Pérez Fidalgo, a physician specializing in oncology and hematology at the Instituto de Investigación Sanitaria Clínico Valencia (Incliva) and a member of the Sociedad Española de Oncología Médica (SEOM), lauded Spain’s healthcare system and its strategies in combating breast cancer between 1990 and 2023. He noted that the decline in mortality in Spain is even greater than the average decrease observed in wealthier nations. “The fact that there are many more new cases and yet mortality has fallen by almost 42% in the same period is a major health achievement that we should celebrate,” he said, also speaking to SMC España.
However, Pérez Fidalgo cautioned that significant differences persist between countries and socioeconomic groups in managing breast cancer. He emphasized that the efforts made in European countries, including Spain, have a positive impact on population health. The study reinforces this point, highlighting the importance of sustained investment in healthcare infrastructure and access to quality care.
Risk Factors and Preventative Measures
The research also identified key risk factors contributing to the burden of breast cancer. Dietary habits, tobacco use, and high blood glucose levels were found to have the most significant impact in terms of disability-adjusted life years (DALYs). Other factors, such as obesity, excessive alcohol consumption, and a sedentary lifestyle, also contribute to risk, albeit to a lesser extent. Addressing these modifiable risk factors through public health initiatives and individual lifestyle changes could play a crucial role in reducing the incidence of breast cancer.
The increasing global burden of breast cancer presents a complex challenge, requiring a multifaceted approach that encompasses early detection, innovative treatments, and preventative measures. As populations continue to age, proactive strategies will be essential to mitigate the projected rise in cases and deaths. Continued research and international collaboration are vital to ensure equitable access to care and improve outcomes for women worldwide.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It’s essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on the future of breast cancer research and treatment? Share your comments below, and please share this article with your network.
